Nucleic Acids Research, 1989, Vol. 17, No. 19 7761-7770
© 1989
MOLECULAR BIOLOGY |
A DNA-binding domain or human transcription factor IIIC2
Molecular Biology Institute and Department of Microbiology, University of California Los Angeles, CA 900241570, USA
+Present address: Laboratoire de Virologie et Pathogenese Moleculaires, Institut de Biologie, Faculté de Medecine, 34060 Montpellier, France
*To whom correspondence should be addressed
Received June 26, 1989. Revised August 25, 1989. Accepted August 25, 1989.
Transcription factor IIIC2 is required for in vitro transcription of the adenovirus 2 VA1 gene and binds with high affinity to its B-box promoter element which is an 18 bp perfect inverted repeat. Partial proteolysis of TFIIIC2 with chymotrypsin and Staphylococcus aureus V8 protease yielded a species which produced a discrete band in a gel shift assay with about twice the mobility of the undigested complex. Chymotrypsin-digested TFIIIC2 produced a DNase I footprint virtually identical to that of the undigested protein, but the stability of the protein-VA1 DNA complex was drastically reduced and the in vitro transcriptional activity was eliminated. These results indicate that a chymotrypsin-resistant domain of TFIIIC2 binds to the B-box sequence. We speculate that stable binding requires protease sensitive cooperative interactions between TFIIIC2 DNA-binding domains.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. D. Colandene and M. D. Topal The domain organization of NaeI endonuclease: Separation of binding and catalysis PNAS, March 31, 1998; 95(7): 3531 - 3536. [Abstract] [Full Text] [PDF] |
||||
